Collegium Pharmaceutical Inc
Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts.
Current Price
$33.78
-3.01%GoodMoat Value
$102.96
204.8% undervaluedProfile
Valuation (TTM)
Market Cap$1.07B
P/E14.31
EV—
P/B3.56
Shares Out31.75M
P/Sales1.35
Revenue$796.33M
EV/EBITDA7.60
Collegium Pharmaceutical Inc (COLL) Stock Analysis
Market Cap$1.07B
Current Price$33.78
P/E Ratio14.31
Forward P/E—
PEG Ratio0.03
EPS$1.73
Book Value$9.50
P/B Ratio3.56
COLL Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use 50.0% FCF growth (CAGR)
Cash vs Debt
Net Debt: 563M
Revenue
297M
FY19
310M
FY20
277M
FY21
464M
FY22
567M
FY23
631M
FY24
781M
FY25
Net Income
—
FY19
27M
FY20
72M
FY21
—
FY22
48M
FY23
69M
FY24
63M
FY25
COLL 52-Week Range
$28.82
$49.84
50-Day MA: $34.53200-Day MA: $39.61
Did you know?
Free cash flow has been growing at 50.0% annually.
Collegium Pharmaceutical Inc (COLL) Financial Summary
Collegium Pharmaceutical Inc (COLL) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ. The stock currently trades at $33.78 with a market capitalization of $1.07B.
Key valuation metrics include a P/E ratio of 14.31, price-to-book ratio of 3.56, and EPS of $1.73. The company reports a profit margin of 9.4% and return on equity of 24.8%.
COLL Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $1.07B |
| P/E Ratio | 14.31 |
| EPS | $1.73 |
| P/B Ratio | 3.56 |
| P/S Ratio | 1.35 |
| EV/EBITDA | 7.60 |
| Profit Margin | 9.4% |
| Return on Equity | 24.8% |
| Debt/Equity | 2.70 |
COLL Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $296.70M | $-22.72M |
| FY20 | $310.02M | $26.75M |
| FY21 | $276.87M | $71.52M |
| FY22 | $463.93M | $-25.00M |
| FY23 | $566.77M | $48.16M |
| FY24 | $631.45M | $69.19M |
| FY25 | $780.57M | $62.87M |
Collegium Pharmaceutical Inc (COLL) Valuation
Based on GoodMoat's DCF model, Collegium Pharmaceutical Inc has a fair value estimate of $102.96. At the current price of $33.78, the stock appears 67.2% undervalued relative to our intrinsic value estimate.
COLL Quality Indicators
Collegium Pharmaceutical Inc maintains a profit margin of 9.4% and an operating margin of 22.9%. Return on equity stands at 24.8%. The current ratio is 1.57. Debt-to-equity ratio is 2.70.
About Collegium Pharmaceutical Inc
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts.
COLL Free Cash Flow
Collegium Pharmaceutical Inc generated $327.58M in trailing twelve-month free cash flow, representing an FCF yield of 30.54%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
COLL Shares Outstanding
Collegium Pharmaceutical Inc has 0.03 billion shares outstanding at a share price of $33.78, giving it a market capitalization of $1.07B.